-
Rob Verkerk joins the Politically Incorrect team on TNT Radio
01 February 2023
Rob Verkerk and the Polictically Incorrect team explore a vast rabbit warren of issues in their latest chat
-
Alzheimer’s disease: cheap nutrients outperform latest drug
05 October 2022
Acclaimed nutritionist Patrick Holford speaks to ANH Founder Rob Verkerk PhD about the Food for the Brain Foundation’s launch of the ‘Alzheimer’s is Preventable’ campaign
-
Beyond the Metabolism: a training day by Britain's top ecological doctors
23 November 2022
A selection of clinical pearls from leading UK doctors — for your benefit
-
Feature: From YouTube to WHO-Tube
02 November 2022
Why we must win the fight for independence from the medico-political complex
News / ANH Covid Zone / Health / Campaigns
-
The What, Why and How of the MRB Model
14 September 2022
Join our free webinar with Rob Verkerk PhD and Jaap Hanekamp PhD introducing the MRB Model. The best risk and benefits management solution for micronutrients in food supplements
-
Pathfinder Members' Briefing and Q&A - October 2022
20 October 2022
Zoom recording of our Pathfinder members' briefing and Q&A for October 2022
-
August Acceleration: Turning a life-defining moment into a life's mission
17 August 2022
Meleni Aldridge speaks to Dr Ben Brown ND about his journey to becoming a naturopath and how it's shaped and influenced his life
-
Join us this Saturday – so we can learn to communicate again!
22 September 2022
Polarisation is rampant, many have lost the ability to talk to each other on touchy subjects – but there’s something you can do about it: this Saturday!
News / ANH Covid Zone / Health / Education
-
Control Group Cooperative survey findings published!
24 August 2022
After significant censorship, the preprint paper we released in June is now in print in revised form in an uncensored peer reviewed journal
News / ANH Covid Zone / Health / Campaigns / Research
-
News Alerts: Week 44, 2017
31 October 2017
ASA continues to target natural health industry; Scottish Government takes ‘bold action’ on obesity; Just how independent will EFSA’s rules make it?; Pharma’s focus on natural products continues